{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05857969",
            "orgStudyIdInfo": {
                "id": "112215"
            },
            "secondaryIdInfos": [
                {
                    "id": "2U54MD012393-06",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/2U54MD012393-06"
                }
            ],
            "organization": {
                "fullName": "Florida International University",
                "class": "OTHER"
            },
            "briefTitle": "Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling",
            "officialTitle": "Adopting a Functional Precision Medicine Approach to Reduce Cancer Disparities in Hispanic and Black Children of Miami",
            "therapeuticArea": [
                "Pediatrics",
                "Oncology and Hematology"
            ],
            "study": "ex-vivo-drug-sensitivity-testing-and-multi-omics-profiling"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-02-22",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-02-22",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-05-05",
            "studyFirstSubmitQcDate": "2023-05-05",
            "studyFirstPostDateStruct": {
                "date": "2023-05-15",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-03",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-04",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Diana Azzam, PhD",
                "investigatorTitle": "Assistant Professor",
                "investigatorAffiliation": "Florida International University"
            },
            "leadSponsor": {
                "name": "Florida International University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Nicklaus Children's Hospital f/k/a Miami Children's Hospital",
                    "class": "OTHER"
                },
                {
                    "name": "First Ascent Biomedical, Inc.",
                    "class": "UNKNOWN"
                },
                {
                    "name": "National Institute on Minority Health and Health Disparities (NIMHD)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Functional precision medicine (FPM) is a relatively new approach to cancer therapy based on direct exposure of patient- isolated tumor cells to clinically approved drugs and integrates ex vivo drug sensitivity testing (DST) and genomic profiling to determine the optimal individualized therapy for cancer patients. In this study, we will enroll relapsed or refractory pediatric cancer patients with tissue available for DST and genomic profiling from the South Florida area, which is 69% Hispanic and 18% Black. Tumor cells collected from tissue taken during routine biopsy or surgery will be tested.",
            "detailedDescription": "PRIMARY OBJECTIVE: The primary objective of the study is to determine feasibility of providing pediatric cancer patients with access to personalized treatment options and clinical management recommendations based on Functional Precision Medicine (FPM), the combination of ex vivo drug sensitivity testing (DST) and genomic profiling.\n\nSECONDARY OBJECTIVE: The secondary objective of the study is to compare individual outcomes (response and disease-free survival) in patients with pediatric cancers treated with FPM-guided therapy as compared to non-FPM guided (conventional) therapy.\n\nEXPLORATORY OBJECTIVE: To explore associations between tumor molecular characteristics (genomic and transcriptomic variation) and ex vivo drug response with respect to patient ethnicity."
        },
        "conditionsModule": {
            "conditions": [
                "Recurrent Childhood Acute Myeloid Leukemia",
                "Recurrent Childhood Acute Lymphoblastic Leukemia",
                "Recurrent Childhood Large Cell Lymphoma",
                "Refractory Childhood Acute Lymphoblastic Leukemia",
                "Refractory Childhood Hodgkin Lymphoma",
                "Refractory Childhood Malignant Germ Cell Neoplasm",
                "Recurrent Childhood Brain Tumor",
                "Recurrent Childhood Brainstem Glioma",
                "Recurrent Childhood Rhabdomyosarcoma",
                "Recurrent Childhood Soft Tissue Sarcoma",
                "Recurrent Childhood Ependymoma",
                "Recurrent Childhood Lymphoblastic Lymphoma",
                "Recurrent Childhood Gliosarcoma",
                "Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive",
                "Refractory Childhood Malignant Solid Neoplasm",
                "Recurrent Childhood Malignant Solid Neoplasm",
                "Recurrent Childhood Malignant Neoplasm",
                "Refractory Childhood Malignant Neoplasm"
            ],
            "keywords": [
                "ex vivo drug sensitivity assay",
                "genomic profiling",
                "Functional precision medicine",
                "Biomarker development"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITH_DNA",
                "description": "Perform functional drug testing and genomic profiling on blood, biopsy, bone marrow and solid tumor samples at relapse."
            },
            "enrollmentInfo": {
                "count": 65,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Chemorefractory or relapsed patients",
                    "description": "We intend to enroll chemorefractory or relapsed pediatric patients with all types of cancers where tumor tissue would be available for ex vivo drug screening and genomic profiling. The results of the drug sensitivity assay and genetic screening will be used to inform treating physician about patient-specific drug sensitivity or resistance guiding best therapy choices."
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percentage of Patients that receive Functional Precision Medicine (FPM)-guided treatment options",
                    "description": "This study will be considered successful (feasibility demonstrated) if it is possible to choose and initiate a monotherapy or combination drug regimen based on functional and/or genomics data within 4 weeks in at least 39 out of 65 patients (60%).\n\nTo achieve at least 90% power, the null hypothesis will be rejected when at least 39 out of 65 patients receive treatment recommendations through functional and/or genomics data within 4 weeks on the study.\n\nWith that outcome, we would have 95% confidence that the true feasibility rate is at least 40% (95% CI: 0.4905 to 1).",
                    "timeFrame": "Up to 6 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Assessing Progression-Free Survival (PFS) in FPM-guided therapy versus standard of care",
                    "description": "We will assess changes in cohort PFS by comparing PFS in patients treated with FPM-guided therapy versus PFS in patients treated with non-FPM guided conventional therapy (standard of care)",
                    "timeFrame": "Up to 6 years"
                },
                {
                    "measure": "Assessing Previous vs Trial PFS Ratio (PFS2/PFS1) in FPM-guided patients versus standard of care",
                    "description": "We will assess changes in PFS from each patient's previous treatment versus their PFS from the treatment assigned during the trial. Assessments will be made both in the FPM-guided cohort and the non-FPM-guided cohort (standard of care). Analysis will include both the raw ratio as well as the number of incidences of 30% improved PFS on trial versus previous regimen (PFS2/PFS1 \\> 1.3x).",
                    "timeFrame": "Up to 6 years"
                },
                {
                    "measure": "Assessing Overall Survival (OS) in FPM-guided patients versus standard of care patients",
                    "description": "We will assess changes in cohort OS by comparing OS in patients treated with FPM-guided therapy versus OS in patients treated with non-FPM guided conventional therapy (standard of care)",
                    "timeFrame": "Up to 6 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients aged 21 years or younger at the time of enrollment on this study of any gender, race or ethnicity.\n\nSubjects with suspected or confirmed diagnosis of recurrent or refractory cancer Subjects who are scheduled for or have recently had biopsy or tumor excised (solid tumors) or bone marrow aspirate (blood cancers) Subjects willing to have a blood draw or buccal swab done for the purposes of genetic testing Subjects or their parents or legal guardians willing to sign informed consent Subjects aged 7 to 17 willing to sign assent\n\nExclusion Criteria:\n\n* Subjects who do not have malignant tissue available and accessible The amount of excised malignant tissue is not sufficient for the ex vivo drug testing and/or genetic profiling.\n\nPatients with newly diagnosed tumors and tumors that have high (\\>90%) cure rate with safe standard therapy.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "1 Day",
            "maximumAge": "21 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ],
            "studyPopulation": "Chemorefractory and/or relapsed pediatric cancer patients with no alternative treatment options.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Diana Azzam, PhD",
                    "role": "CONTACT",
                    "phone": "305-348-9043",
                    "email": "fpmlab@fiu.edu"
                },
                {
                    "name": "Lillian Garvin",
                    "role": "CONTACT",
                    "phone": "800-533-1792",
                    "email": "exvivotrial@nicklaushealth.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Diana Azzam",
                    "affiliation": "Florida International University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Maggie Fader",
                    "affiliation": "Nicklaus Children's Hospital",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Nicklaus Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33155",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Darika Sartmatova",
                            "role": "CONTACT",
                            "phone": "800-533-1792",
                            "email": "exvivotrial@nicklaushealth.org"
                        },
                        {
                            "name": "Lillian Garvin",
                            "role": "CONTACT",
                            "phone": "800-533-1792",
                            "email": "exvivotrial@nicklaushealth.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008223",
                    "term": "Lymphoma"
                },
                {
                    "id": "D000007938",
                    "term": "Leukemia"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000012509",
                    "term": "Sarcoma"
                },
                {
                    "id": "D000054198",
                    "term": "Precursor Cell Lymphoblastic Leukemia-Lymphoma"
                },
                {
                    "id": "D000007945",
                    "term": "Leukemia, Lymphoid"
                },
                {
                    "id": "D000007951",
                    "term": "Leukemia, Myeloid"
                },
                {
                    "id": "D000015464",
                    "term": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive"
                },
                {
                    "id": "D000012208",
                    "term": "Rhabdomyosarcoma"
                },
                {
                    "id": "D000004806",
                    "term": "Ependymoma"
                },
                {
                    "id": "D000018316",
                    "term": "Gliosarcoma"
                },
                {
                    "id": "D000009373",
                    "term": "Neoplasms, Germ Cell and Embryonal"
                },
                {
                    "id": "D000012008",
                    "term": "Recurrence"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000018204",
                    "term": "Neoplasms, Connective and Soft Tissue"
                },
                {
                    "id": "D000009196",
                    "term": "Myeloproliferative Disorders"
                },
                {
                    "id": "D000001855",
                    "term": "Bone Marrow Diseases"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000009217",
                    "term": "Myosarcoma"
                },
                {
                    "id": "D000009379",
                    "term": "Neoplasms, Muscle Tissue"
                },
                {
                    "id": "D000005910",
                    "term": "Glioma"
                },
                {
                    "id": "D000018302",
                    "term": "Neoplasms, Neuroepithelial"
                },
                {
                    "id": "D000017599",
                    "term": "Neuroectodermal Tumors"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009380",
                    "term": "Neoplasms, Nerve Tissue"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9020",
                    "name": "Glioma",
                    "relevance": "LOW"
                },
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14850",
                    "name": "Recurrence",
                    "asFound": "Recurrent",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10018",
                    "name": "Hypersensitivity",
                    "relevance": "LOW"
                },
                {
                    "id": "M27585",
                    "name": "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
                    "asFound": "Acute Lymphoblastic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15327",
                    "name": "Sarcoma",
                    "asFound": "Soft Tissue Sarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15037",
                    "name": "Rhabdomyosarcoma",
                    "asFound": "Rhabdomyosarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10945",
                    "name": "Leukemia",
                    "asFound": "Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10951",
                    "name": "Leukemia, Lymphoid",
                    "asFound": "Lymphoblastic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18123",
                    "name": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive",
                    "asFound": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10955",
                    "name": "Leukemia, Myeloid",
                    "asFound": "Myelogenous Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18127",
                    "name": "Leukemia, Myeloid, Acute",
                    "relevance": "LOW"
                },
                {
                    "id": "M5209",
                    "name": "Brain Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M9751",
                    "name": "Hodgkin Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M7965",
                    "name": "Ependymoma",
                    "asFound": "Ependymoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20460",
                    "name": "Gliosarcoma",
                    "asFound": "Gliosarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12318",
                    "name": "Neoplasms, Germ Cell and Embryonal",
                    "asFound": "Germ Cell Neoplasm",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "M20350",
                    "name": "Neoplasms, Connective and Soft Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "M12149",
                    "name": "Myeloproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5134",
                    "name": "Bone Marrow Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M12169",
                    "name": "Myosarcoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M20446",
                    "name": "Neoplasms, Neuroepithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M19845",
                    "name": "Neuroectodermal Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20388",
                    "name": "Neuroectodermal Tumors, Primitive",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12325",
                    "name": "Neoplasms, Nerve Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "T2519",
                    "name": "Glioma",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T175",
                    "name": "Acute Lymphoblastic Leukemia",
                    "asFound": "Acute Lymphoblastic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3533",
                    "name": "Lymphoblastic Lymphoma",
                    "asFound": "Acute Lymphoblastic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "T5284",
                    "name": "Soft Tissue Sarcoma",
                    "asFound": "Soft Tissue Sarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1134",
                    "name": "Childhood Acute Lymphoblastic Leukemia",
                    "asFound": "Childhood acute lymphoblastic leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1309",
                    "name": "Chronic Myeloid Leukemia",
                    "asFound": "Chronic Myelogenous Leukemia, BCR-ABL1 Positive",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3995",
                    "name": "Myeloid Leukemia",
                    "relevance": "LOW"
                },
                {
                    "id": "T182",
                    "name": "Acute Myeloid Leukemia",
                    "asFound": "Acute Myeloid Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T188",
                    "name": "Acute Non Lymphoblastic Leukemia",
                    "relevance": "LOW"
                },
                {
                    "id": "T2817",
                    "name": "Hodgkin Lymphoma",
                    "asFound": "Hodgkin Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2093",
                    "name": "Ependymoma",
                    "asFound": "Ependymoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T170",
                    "name": "Acute Graft Versus Host Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "T2475",
                    "name": "Germ Cells Tumors",
                    "asFound": "Germ Cell Neoplasm",
                    "relevance": "HIGH"
                },
                {
                    "id": "T852",
                    "name": "Brain Tumor, Childhood",
                    "asFound": "Childhood brain tumor",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2522",
                    "name": "Gliosarcoma",
                    "asFound": "Gliosarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1136",
                    "name": "Childhood Brain Stem Glioma",
                    "asFound": "Childhood brainstem glioma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3579",
                    "name": "Malignant Germ Cell Tumor",
                    "asFound": "Malignant Germ Cell Neoplasm",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1311",
                    "name": "Chronic Myeloproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "T4092",
                    "name": "Neuroepithelioma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}